Lumonus与MSK合作,为自动化辐射治疗计划提供AI许可. Lumonus partners with MSK to license AI for automated radiation treatment planning.

放射性瘤学AI公司Lumonus宣布与斯隆凯特林纪念癌症中心合作,授权并共同开发MSK ECHO引擎用于自动化治疗计划. Lumonus, a radiation oncology AI company, announced a collaboration with Memorial Sloan Kettering Cancer Center to license and co-develop the MSK ECHO engine for automated treatment planning. 这项合作旨在通过将严格的数学优化与临床工作流程相结合,提高剂量计质量和效率,从而迈出了使自动化成为癌症护理常规的一步. The partnership aims to enhance dosimetric quality and efficiency by integrating rigorous mathematical optimization with clinical workflows, marking a step toward making automation routine in cancer care.